the genesis of such ulcers.1' 2 As a matter of fact, some authors have recommended that the administration of enteric-coated tablets be discontinued.3 These considerations may lead some physicians to neglect the need for continued careful evaluation of patients, receiving diuretic therapy, for manifestations of potassium deficiency. The purpose of this report is to (1) illustrate the rapidity with which potassium deficits may develop in patients during administration of combinations of diuretics to these patients, and (2) the usefulness of body composition measurements in clinical medicine. The data reported here were obtained during the course of a study designed to test the hypothesis that the hypokalemia associated with the administration of thiazide diuretics reflects a redistribution of potassium rather than a depletion of body potassium.
Hollander and associates, 4 have reported that 4 to 8 weeks of chlorothiazide administration to hypertensive patients produced a significant decrease in the exchangeable potassium content of these patients. Talso None of these patients were in the malignant or accelerated phase of hypertensive disease at the time of these studies, and none exhibited evidences of congestive heart failure. The only dietary restriction was sodium. All electrolyte studies were performed while the patients were fasting. The methods used for measuring exchangeable potassium, total body potassium, and total body water have been described elsewhere.6 7 The methods used for serum pH, chloride, bicarbonate, sodium, and potassium were described by Talso and Carballo.5 Extracellular fluid volume was measured using radiosulfate assayed by the method of Jeffay and associates.8
After the initial measurements were made, hydrochlorothiazide 50 mg and dichlorphenamide 50 mg were administered twice a day. This regimen was maintained for 4 weeks and at the end of this period all of the measurements were repeated. One patient was restudied several months later after his diet was supplemented with potassium chloride tablets.
Results
The results obtained in this study are tabulated in tables 2 and 3. Though there was no clinical evidence of edema, all of the patients lost weight during treatment. Where replicate measurements of total body water and extracellular fluid volume are available, it is evident that the weight loss can be accounted for by a decrease in extracellular fluid volume. These patients lost large amounts of their body potassium. Two independent techniques were used to measure body potassium: (1) the total exchangeable technique, and (2) the whole body counter technique. For each method the losses are highly significant.6 9 There was a significant decrease of the serum potassium and chloride during treatment. There was no significant change of serum sodium, bicarbonate, or pH.
Discussion
It is readily apparent that this regimen of combined hydrochlorothiazide and dichlorophenamide therapy produced a marked decrease in the body content of potassium of these subjects. These losses were significantly larger than those that would be expected from the decrease in body weight observed. They were accompanied by a significant decrease in the patient's serum potassium and chloride with no significant change in the values for serum sodium, bicarbonate, or pH. It is evident that these data do not support the hypothesis that the hypokalemia observed during the administration of thiazide diuretics to hypertensive patients results principally from redistribution of body potassium as suggested by Talso and Carballo.5 They confirm, however, observations of Hollander and associates.4 The fact that the clinicians observing these patients did not report any clinical evidence for a deficit of body potassium is of interest.
Several mechanisms may be responsible for the rapid development of this marked deficit.
Ford and Rochelle'0 have shown that chlorothiazide and acetazolamide share one mechanism of action upon the renal tubular cell, carbonic anhydrase inhibition, but chlorothiazide also has other mechanisms. By the use of the stop-flow technique, Kessler has shown that in the kidney hydrochlorothiazide acts predominantly on the proximal tubular segment while dichlorphenamide acts on the distal tubular segment.1' During simultaneous administration of these compounds, hydrochlorothiazide inhibits the reabsorption of electrolytes in the proximal tubular segment so that the sodium load presented distally will be increased. Inhibition of carbonic anhydrase in the distal tubular segment limits the amount of H+ available for exchange with filtered sodium. Normally hydrogen and potassium ions in the cells of the distal tubular segment are exchanged with the sodium ions in the lumen of the tubule. When the supply of hydrogen ions is diminished, only potassium exchanges with sodium; the net result is an enhancement of potassium secretion which is further augmented by the larger sodium load presented to the distal tubular segment. In addition, these patients probably developed a mild degree of secondary aldosteronism due to the restriction of sodium in their diet. Sackner and associates12 have shown that when secondary aldosteronism is produced by the administration of desoxycorticosterone acetate, the simultaneous administration of hydrochlorothiazide produces a significantly greater kaluretic effect than that of the sum of the two given separately.
It is necessary to emphasize the fact that severe deficits of body potassium can be produced by this regimen since combinations of thiazides and carbonic anhydrase inhibitors have been recommended for the management of patients with intractable heart failure."3 These data also serve to illustrate the usefulness of body composition techniques in clinical medicine. 
